Skip to content
healthcare.dev
Get a free key

LEXISCAN

NDC 0469-6501, regadenoson, injection, solution, from Astellas Pharma US, Inc..

Product NDC
0469-6501
Status
Listed
Labeler
Astellas Pharma US, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022161
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0469-6501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]

Package NDCNDC-11Package
0469-6501-89004696501895 mL in 1 SYRINGE, PLASTIC (0469-6501-89)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/057289f4-2e18-4c1e-bed4-6c1858e2ef16

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0469-6501

Use it

Look up 0469-6501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0469-6501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0469-6501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.